Search Results

There are 19119 results for: content related to: Effect of Phenylpropanolamine and Pseudoephedrine on the Urethral Pressure Profile and Continence Scores of Incontinent Female Dogs

  1. Evaluation of the Potential for Pharmacodynamic and Pharmacokinetic Drug Interactions Between Selegiline Transdermal System and Two Sympathomimetic Agents (Pseudoephedrine and Phenylpropanolamine) in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 8, August 2007, Pages: 978–990, Dr. Albert J. Azzaro, Dr. Chad M. VanDenBerg, Dr. John Ziemniak, Ms Eva M. Kemper, Dr. Lawrence F. Blob and Dr. Bryan J. Campbell

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007302950

  2. A pharmacodynamic interaction between caffeine and phenylpropanolamine

    Clinical Pharmacology & Therapeutics

    Volume 50, Issue 4, October 1991, Pages: 363–371, Nancy J Brown, Diane Ryder and Robert A Branch

    Version of Record online : 17 OCT 1991, DOI: 10.1038/clpt.1991.152

  3. You have free access to this content
    Double-Blind, Randomized, Placebo-Controlled Clinical Trials with Non-Prescription Medications for the Treatment of Obesity

    Obesity Research

    Volume 7, Issue 4, July 1999, Pages: 370–378, Frank Greenway, David Heber, William Raum and Silvia Morales

    Version of Record online : 6 SEP 2012, DOI: 10.1002/j.1550-8528.1999.tb00420.x

  4. Pharmacology and safety of phenylpropanolamine

    Drug Development Research

    Volume 22, Issue 3, 1991, Pages: 197–207, David A. Johnson

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430220302

  5. Dose-Dependent Response to Phenylpropanolamine: Inhibition of Orthostasis

    The Journal of Clinical Pharmacology

    Volume 31, Issue 7, July 1991, Pages: 624–635, Dr. C. Raymond Lake, David B. Rosenberg, Dr. Sheryle Gallant, Gary Zaloga and Bart Chernow

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1991.tb03748.x

  6. Dispositional factors do not contribute to the enantiospecificity of the cardiovascular effects of phenylpropanolamine

    Clinical Pharmacology & Therapeutics

    Volume 55, Issue 1, January 1994, Pages: 35–43, Creina S Stockley, Lindon M H Wing, Anne L Tonkin and John O Miners

    Version of Record online : 16 JAN 1994, DOI: 10.1038/clpt.1994.7

  7. Effect of phenylpropanolamine on incontinence in children with neurogenic bladders. A double-blind crossover study

    Acta Paediatrica

    Volume 81, Issue 4, April 1992, Pages: 345–350, P Åmark and O Beck

    Version of Record online : 21 JAN 2008, DOI: 10.1111/j.1651-2227.1992.tb12240.x

  8. Bioavailability and cardiovascular safety of dexatrim® (phenylpropanolamine hydrochloride) from a controlledrelease caplet

    Biopharmaceutics & Drug Disposition

    Volume 11, Issue 7, October 1990, Pages: 569–583, Leon Shargel, Harold I. Silverman, Peri Cohen, Jerry Brisson and Susana Dennis

    Version of Record online : 11 JAN 2006, DOI: 10.1002/bdd.2510110703

  9. The Effect of Multiple Doses of Phenylpropanolamine on the Blood Pressure of Patients Whose Hypertension Was Controlled With β Blockers

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 11, Issue 5, September-October 1991, Pages: 376S–381S, Mary Beth O'Connell and Dr. Cynthia R. Gross

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1991.tb02648.x

  10. Mediation of oxidative stress in hypothalamic ghrelin-associated appetite control in rats treated with phenylpropanolamine

    Genes, Brain and Behavior

    Accepted manuscript online: 8 NOV 2016, Ching-Han Yu, Shu-Chen Chu, Pei-Ni Chen, Yih-Shou Hsieh and Dong-Yih Kuo

    DOI: 10.1111/gbb.12360

  11. Pharmacokinetics of Oral Decongestants

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 13, Issue 6P2, November-December 1993, Pages: 116S–128S, Isadore Kanfer, Roslind Dowse and Vusumuzi Vuma

    Version of Record online : 19 JAN 2012, DOI: 10.1002/j.1875-9114.1993.tb02780.x

  12. Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses

    Biopharmaceutics & Drug Disposition

    Volume 8, Issue 5, September/October 1987, Pages: 497–505, Munir A. Hussain, Bruce J. Aungst, Gilbert Lam and Eli Shefter

    Version of Record online : 8 FEB 2006, DOI: 10.1002/bdd.2510080509

  13. The effect of topical phenylpropanolamine on nasal secretion and nasal airway resistance after histamine challenge in man

    Clinical Otolaryngology & Allied Sciences

    Volume 10, Issue 1, February 1985, Pages: 15–19, S. LÖTH and M. BENDE

    Version of Record online : 2 AUG 2007, DOI: 10.1111/j.1365-2273.1985.tb01159.x

  14. Oral Vasoconstrictors in Perennial Non-Allergic Rhinitis

    Allergy

    Volume 37, Issue 2, February 1982, Pages: 67–74, P. Broms and L. Malm

    Version of Record online : 28 APR 2007, DOI: 10.1111/j.1398-9995.1982.tb01879.x

  15. Adrenergic drugs for urinary incontinence in adults

    Intervention Review

    The Cochrane Library

    Ammar Alhasso, Cathryn MA Glazener, Robert Pickard and James MO N'Dow

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD001842.pub2

  16. The effect of phenylpropanolamine on ambulatory blood pressure

    Clinical Pharmacology & Therapeutics

    Volume 40, Issue 2, August 1986, Pages: 144–147, Robert P Goodman, Jackson T Wright Jr, Cornelius O Barlascini, James M McKenney and Carolyn M Lambert

    Version of Record online : 18 AUG 1986, DOI: 10.1038/clpt.1986.153

  17. Analysis of Phenylpropanolamine by Micellar Electroknetic Chromatography with Laser-induced Fluorescence Detection

    Journal of the Chinese Chemical Society

    Volume 52, Issue 4, August 2005, Pages: 827–831, Fu-Ming Chou and Chen-Wen Whang

    Version of Record online : 25 SEP 2013, DOI: 10.1002/jccs.200500116

  18. Phenylpropanolamine: Effects on Subjective and Cardiovascular Variables at Recommended Over-the-Counter Dose Levels

    The Journal of Clinical Pharmacology

    Volume 27, Issue 9, September 1987, Pages: 685–693, Ira Liebson, George Bigelow, Roland R. Griffiths and Frank R. Funderburk

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1987.tb03089.x

  19. Propranolol antagonism of phenylpropanolamine-induced hypertension

    Clinical Pharmacology & Therapeutics

    Volume 37, Issue 5, May 1985, Pages: 488–494, Paul R Pentel, Richard W Asinger and Neal L Benowitz

    Version of Record online : 13 MAY 1985, DOI: 10.1038/clpt.1985.77

  20. You have free access to this content
    Acute Administration of Phenylpropanolamine Fails to Affect Resting Energy Expenditure in Men of Normal Weight

    Obesity Research

    Volume 5, Issue 5, September 1997, Pages: 470–473, Paul A. Rushing, Suzan E. Winders, Sheree L. Watson and Robert C. Klesges

    Version of Record online : 6 SEP 2012, DOI: 10.1002/j.1550-8528.1997.tb00673.x